3.0
Jan 14, 2014
Former employee, more than 1 year
Plymouth Meeting, PA
Recommend
CEO approval
Business Outlook
Pros
good processes and procedures within the data business - recently the organization has been focusing on acquisitions in order to diversify its business. strong knowledge on pharma and stronger hold on pharma companies that most of players in the space...
Cons
poorly executed integration...lots of red tape...you are just a number so do not be surprised if you are relocated, removed, or reassigned without notice. emerging business areas are not thought through...lots of smoke and mirrors...